PTC Therapeutics Inc
NASDAQ:PTCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
US |
|
N
|
Nestle SA
SWB:NESM
|
CH |
|
F
|
Factset Research Systems Inc
SWB:FA1
|
US |
|
R
|
Reservoir Media Inc
F:0RL0
|
US |
|
N
|
Northrop Grumman Corp
LSE:0K92
|
US |
|
I
|
International Consolidated Airlines Group SA
F:INRA
|
UK |
|
B
|
Becton Dickinson and Co
F:BOX
|
US |
|
M
|
Martin Marietta Materials Inc
BMV:MLM
|
US |
|
Hasbro Inc
NASDAQ:HAS
|
US |
|
C
|
CSL Ltd
XMUN:CSJ
|
AU |
|
M
|
Morgan Stanley
BMV:MS
|
US |
|
M
|
Monster Beverage Corp
SWB:MOB
|
US |
|
P
|
Pfizer Inc
F:PFE
|
US |
|
P
|
Publicis Groupe SA
OTC:PGPEF
|
FR |
|
S
|
Swiss Prime Site AG
XMUN:SU1N
|
CH |
|
A
|
Alphabet Inc
XETRA:ABEA
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PTCT's stock price target?
Price Target
106.08
USD
According to Wall Street analysts, the average 1-year price target for
PTCT is 106.08 USD with a low forecast of 70.7 USD and a high forecast of 136.5 USD.